Josselin BRISSET

Dr. Josselin BRISSET

Service de Médecine Interne, CHU Dupuytren, Limoges
+1

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
JBJosselin BRISSET
Josselin BRISSET
KBKarl Angendu Baki
Karl Angendu Baki
LWLaurence Watier
Laurence Watier
EKElisée Kinkpé
Elisée Kinkpé
JBJustine Bailly
Justine Bailly
BVBertin Vianou
Bertin Vianou
Background: While malaria morbidity and mortality have declined since 2000, viral central nervous system infections appear to be an important, underestimated cause of coma in malaria-endemic Eastern Africa. We aimed to describe the etiology of non-traumatic comas in young children in Benin, as well as their management and early outcomes, and to identify factors associated with death. Methods: From March to November 2018, we enrolled all HIV-negative children aged between 2 and 6 years, with a Blantyre Coma Score ≤ 2, in this prospective observational study. Children were screened for malaria severity signs and assessed using a systematic diagnostic protocol, including blood cultures, malaria diagnostics, and cerebrospinal fluid analysis using multiplex PCR. To determine factors associated with death, univariate and multivariate analyses were performed. Results: From 3244 admissions, 84 children were included: malaria was diagnosed in 78, eight of whom had a viral or bacterial co-infection. Six children had a non-malarial infection or no identified cause. The mortality rate was 29.8% (25/84), with 20 children dying in the first 24 h. Co-infected children appeared to have a poorer prognosis. Of the 76 children who consulted a healthcare professional before admission, only 5 were prescribed adequate antimalarial oral therapy. Predictors of early death were jaundice or increased bilirubin [odd ratio (OR)= 8.6; 95% confidential interval (CI): 2.03–36.1] and lactate > 5 mmol/L (OR = 5.1; 95% CI: 1.49–17.30). Antibiotic use before admission (OR = 0.1; 95% CI: 0.02–0.85) and vaccination against yellow fever (OR = 0.2, 95% CI: 0.05–0.79) protected against mortality. Conclusions: Infections were found in all children who died, and cerebral malaria was by far the most common cause of non-traumatic coma. Missed opportunities to receive early effective antimalarial treatment were common. Other central nervous system infections must be considered in their management. Some factors that proved to be protective against early death were unexpected.

Verified
Journal Article
Open access
PDF file
JBJosselin BRISSET
Josselin BRISSET
YJYvan JAMILLOUX
Yvan JAMILLOUX
SDStephanie Dumonteil
Stephanie Dumonteil
GLGuillaume Lades
Guillaume Lades
MKMartin Killian
Martin Killian
KLKim Heang Ly
Kim Heang Ly
While the diagnosis of adult-onset Still’s disease (AOSD) involves the exclusion of differential diagnoses, the characteristics and value of 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography coupled with CT (PET/CT) in the management of AOSD remain poorly known. Our retrospective study included patients from four centers, fulfilling Yamaguchi or Fautrel criteria, who underwent a PET/CT during an active AOSD. Thirty-five patients were included. At the time of PET/CT, the Yamaguchi criteria were met in 23 of 29 evaluable cases. PET/CT showed bone marrow (74.3%), lymph node (74.3%), and splenic (48.6%) FDG uptake. Despite arthralgia or arthritis in most patients, joints were rarely the sites of 18F-FDG accumulation. The spatial distribution of 18F-FDG uptake was nonspecific, and its intensity could be similar to malignant disease. Lymph node or bone marrow biopsy was performed after PET/CT in 20 patients (57.1%). The intensity of bone marrow; splenic and lymph node hypermetabolism appeared to be correlated with disease activity. Abnormal PET/CT in the cervical lymph nodes and age ≥ 60 years seemed to be predictive factors for monocyclic evolution. The clinical value of PET/CT is not in direct diagnosis; but as an aid in excluding differential diagnoses by searching for their scintigraphic features and guiding biopsy.

19 May 2020 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JBJosselin BRISSET
Josselin BRISSET
TDThomas Daix
Thomas Daix
JTJérémy Tricard
Jérémy Tricard
BEBruno Evrard
Bruno Evrard
PVPhilippe Vignon
Philippe Vignon
BFBruno François
Bruno François
Background: Mediastinitis caused by hematogenous spread of an infection is rare. We report the first known case of community-acquired mediastinitis from hematogenous origin in an immunocompetent adult. This rare invasive infection was due to Panton-Valentine Leucocidin-producing (PVL+) methicillin-susceptible Staphylococcus aureus (MSSA). Case presentation: A 22-year-old obese man without other medical history was hospitalized for febrile precordial chest pain. He reported a cutaneous back abscess 3 weeks before. CT-scan was consistent with mediastinitis and blood cultures grew for a PVL+ MSSA. Intravenous clindamycin (600 mg t.i.d) and cloxacillin (2 g q.i.d.), secondary changed for fosfomycin (4 g q.i.d.) because of a related toxidermia, was administered. Surgical drainage was performed and confirmed the presence of a mediastinal abscess associated with a fistula between the mediastinum and right pleural space. All local bacteriological samples also grew for PVL+ MSSA. In addition to clindamycin, intravenous fosfomycin was switched to trimethoprim-sulfamethoxazole after 4 weeks for a total of 10 weeks of antibiotics. Conclusions: We present the first community-acquired mediastinitis of hematogenous origin with PVL+ MSSA. Clinical evolution was favorable after surgical drainage and 10 weeks of antibiotics. The specific virulence of MSSA PVL+ strains played presumably a key role in this rare invasive clinical presentation.

1 June 2018 in La Revue de Médecine Interne
Verified
Journal Article
Closed access
JBJosselin BRISSET
Josselin BRISSET
ELE. Liozon
E. Liozon
GGG. Gondran
G. Gondran
HBH. Bézanahary
H. Bézanahary
SPS. Palat
S. Palat
KLK.H. Ly
K.H. Ly

21 August 2020 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
ACA. Cypierre
A. Cypierre
BGB. Gutierrez
B. Gutierrez
NPN. Pestourie
N. Pestourie
PPP. Pinet
P. Pinet
HDH. Durox
H. Durox
JFJ. Faucher
J. Faucher

21 August 2020 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
JBJosselin BRISSET
Josselin BRISSET
EKE. Kinkpé
E. Kinkpé
JBJ. Bailly
J. Bailly
LAL. Ayédadjou
L. Ayédadjou
JAJ. Alao
J. Alao
JFJ. Faucher
J. Faucher